Adamis Pharmaceuticals have just received FDA approval for their new prefilled epinephrine syringe, Symjepi. The syringe contains 0.3 mg of epinephrine. Adamis Pharmaceuticals are currently seeking approval for a 0.15 mg syringe also.
The price of the Symjepi syringe has not yet been set but Adamis have said that it will be cheaper than the EpiPen® epinephrine auto-injector. It should be on shelves in the US later this year.
Maker’s Adamis say that the Symjepi injector is smaller than the EpiPen® and easier to use.
The new injector could take market share away from Mylan’s EpiPen® injectors. The company came under fire last year for the price of their auto-injector which had increased nearly 500% in price over the course of 7 years. The company lost more than 25% of its share in the market since the beginning of 2016.
How it’s used
Symjepi is a single use prefilled syringe and cannot be reused. This syringe differs from the standard auto-injectors as there is no spring-loaded needle. The syringe has a needle cap which must be pulled off to expose the needle. The needle is then inserted into the thigh and the plunger on top is pushed until it clicks.
Disclaimer: The information provided is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis or treatment. Allergy Lifestyle Limited (t/a) Allergy Lifestyle) uses reasonable endeavours to check the accuracy of information provided however no warranty is given that they are error-free. Always seek the advice of an allergy specialist and follow your anaphylaxis emergency care plan.